Special Delivery: Macromolecules via Spider's 'Bite'

Scientists at Kyoto University have used a reengineered spider venom peptide to deliver biomacromolecules into a cell

Written byKyoto University
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Researchers re-engineer spider venom so that endosomes can deliver its cargo more effectively within cells.Image Credit: Kyoto UniversityOur cells are rich in proteins which are potential targets for therapy. But study of these proteins' behavior, using externally delivered biomacromolecules, has often been stymied by the difficulty of gaining access to the interiors of living cells.

Now scientists at Kyoto University have used a reengineered spider venom peptide to deliver biomacromolecules—such as an antibody—into a cell. Their strategy, appearing in Nature Chemistry, not only allows researchers to track the antibodies visually, but also makes it possible for the antibodies to interact with target proteins, modulating their functions.

"Efficient labeling of intracellular proteins with antibodies allows us to dramatically improve our understanding of their behavior and significance," explains first author Misao Akishiba. "Cells can take in antibodies through membrane-bound vesicles called 'endosomes'. But normally once inside these endosomes, the antibodies have trouble escaping."

Lab manager academy logo

Advanced Lab Management Certificate

The Advanced Lab Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

The researchers found that a simple redesign of spider venom peptide 'M-lycotoxin' enables the efficient release of antibodies from their endosome cages.

"We took M-lycotoxin and replaced a leucine residue with glutamic acid, which we then called 'L17E'," continues Akishiba. "When L17E enters the cell, it specifically interacts with endosome membranes, breaking them down and releasing the antibodies."

The research team then showed that functional antibodies, such as those involved in suppressing gene expression, could be delivered as well.

"This will benefit not only basic science, but also the development of new treatments and drugs," concludes team leader Shiroh Futaki. "Moreover, this tool could potentially be used to transport other bioactive macromolecules -- and even nanoparticles -- into cells."

Interested in life sciences?

Subscribe to our free Life Sciences Newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

By subscribing, you agree to receive email related to Lab Manager content and products. You may unsubscribe at any time.

As a next step, the researchers hope to improve the efficiency of macromolecule uptake by endosomes, thereby increasing the amount of cargo that can be transported.

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - May/June 2025

The Benefits, Business Case, And Planning Strategies Behind Lab Digitalization

Joining Processes And Software For a Streamlined, Quality-First Laboratory

Lab Manager May/June 2025 Cover Image